TickerFactsScreenerDevelopers

MADRIGAL PHARMACEUTICALS, INC. (MDGL) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: $79.30M2010: -$36.90M2011: -$45.43M2012: -$60.94M2013: -$87.56M2014: -$83.95M2015: -$3.23M2016: -$25.22M2017: -$32.06M2018: -$40.68M2019: -$94.97M2020: -$206.67M2021: -$242.48M2022: -$293.57M2023: -$380.50M2024: -$497.88M2025: -$300.10M-$300.10M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$300.10M+39.7%
2024-$497.88M-30.8%
2023-$380.50M-29.6%
2022-$293.57M-21.1%
2021-$242.48M-17.3%
2020-$206.67M-117.6%
2019-$94.97M-133.4%
2018-$40.68M-26.9%
2017-$32.06M-27.1%
2016-$25.22M-680.2%
2015-$3.23M+96.1%
2014-$83.95M+4.1%
2013-$87.56M-43.7%
2012-$60.94M-34.1%
2011-$45.43M-23.1%
2010-$36.90M-146.5%
2009$79.30M—